The CDC estimates that that almost a third of Americans are now overweight and 42% of adults have obesity, now categorized as a disease
Researchers recently conducted a review to examine what effects GLP-1 medications may have on cognitive functioning and mental health issues
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Participants receiving tirzepatide alongside apitegromab retained significantly more lean mass than those receiving tirzepatide and placebo, while achieving broadly comparable overall reductions in body weight
Patients taking semaglutide also showed markedly lesser declines of a key metric of kidney function called the estimated glomerular filtration rate, which was particularly pronounced among those with low baseline readings indicative of impairment, the researchers said, suggesting the drug may help protect people with pre-existing kidney impairments
If you are already familiar with GLP-1 microdosing schedules, the approach follows a similar logic